About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,885 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 881-900 of 10,885 trials

CompletedA Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of CancersIn this study, adults with non-small-cell lung cancer (NSCLC), triple-negative breast cancer (TNBC) and squamous-cell carcinoma of the head and neck (SCCHN) will be treated with…NCT04879849·Duarte, California and 4 others CompletedLow-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway GliomaThis randomized phase II trial studies how well low-dose lenalidomide works compared with high-dose lenalidomide in treating younger patients with juvenile pilocytic astrocytomas…NCT01553149·Birmingham, Alabama and 125 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedDalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma MultiformeRATIONALE: Dalteparin may stop the growth of cancer by stopping blood flow to the tumor and by blocking the enzymes necessary for tumor cell growth.NCT00028678·Tampa, Florida and 11 others

CompletedChemotherapy Drug Sensitivity Microculture (MiCK) Assay for ApoptosisDiaTech is a private company performing patient specific cancer chemosensitivity testing for patients and physicians.NCT00243685·Nashville, Tennessee and 2 others

Active not recruitingTesting Immunotherapy Versus Observation in Patients With HPV Throat CancerThis phase III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiation and chemotherapy (cisplatin) result in significant…NCT03811015·Fairhope, Alabama and 726 others

TerminatedStudy to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple MyelomaThe primary objective of the study is to evaluate the safety and tolerability of KITE-585, an autologous engineered chimeric antigen receptor (CAR) T-cell product targeting a…NCT03318861·Los Angeles, California and 8 others

CompletedRandomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on HemodialysisThe purpose of this clinical study is to compare the effects of Genz-644470 with the effects of placebo and sevelamer carbonate (Renvela®) on the reduction of serum phosphorus in…NCT00853242·Alexander City, Alabama and 52 others

CompletedAn Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature InfantsThe primary objective is to assess the burden of respiratory disease in outpatient settings among 32 to 35 weeks' gestational age (wGA) infants in the USA who did not receive RSV…NCT00983606·Birmingham, Alabama and 221 others

CompletedStudy to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the BrainThis is a multi-cohort, open label, Phase II study with Dabrafenib (GSK2118436) and Trametinib (GSK1120212) combination therapy in subject with BRAF mutation-positive melanoma…NCT02039947·Birmingham, Alabama and 46 others

CompletedExenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes MellitusThis study will compare the impact of including exenatide once weekly in addition to usual care vs. usual care without exenatide on major cardiovascular outcomes as measured by…NCT01144338·Birmingham, Alabama and 628 others

TerminatedExtension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)The primary objective of this extension study (GS-US-312-0117) that is a companion study to Study GS-US-312-0116 (NCT01539512), is to evaluate the effect of idelalisib on the…NCT01539291·Huntsville, Alabama and 44 others

RecruitingOutcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac ProceduresThe incidence of moderate to severe congenital heart disease (CHD) in the United States is estimated to be 6 per 1000 live-born full term infants.NCT04604418·Los Angeles, California and 9 others

Active not recruitingPhase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and LymphomasThis is an open-label, dose-escalation Phase 1/2 study to assess the safety of ASTX660, determine the maximum tolerated dose (MTD), recommended Phase 2 dose (RP2D), and…NCT02503423·Birmingham, Alabama and 67 others

RecruitingA Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid TumorsThis is a Phase Ia/Ib open-label, dose-escalation study to evaluate the safety and pharmacokinetics of ROSE12 as a single agent and in combination with other anti-tumor agents in…NCT05907980·Philadelphia, Pennsylvania and 13 others

CompletedStudy to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic HypotensionThe purpose of this clinical study is to evaluate the clinical effect of midodrine hydrochloride (ProAmatine®) compared to placebo in patients with orthostatic hypotension by…NCT00555880·Fort Wayne, Indiana and 10 others

CompletedDanazol in Treating Patients With Advanced or Recurrent Endometrial CancerRATIONALE: Hormone therapy may be an effective treatment for endometrial cancer.NCT00003946·Birmingham, Alabama and 72 others

CompletedPeds Sanofi H1N1 Influenza Vaccine Administered at Two Dose LevelsThe purpose of this study is to assess the safety and the body's immune response (body's defense against disease) to an experimental H1N1 influenza vaccine.NCT00944073·Baltimore, Maryland and 8 others

TerminatedA Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast CancerThis is a two-part open label, non-randomized, Phase 2, study of ZEN003694 in combination with Talazoparib in patients with TNBC without germline mutations of BRCA1 or BRCA2.NCT03901469·Gilbert, Arizona and 18 others

TerminatedA Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative ColitisA Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults with Active Mild-to-Moderate Ulcerative ColitisNCT03759041·Phoenix, Arizona and 92 others

RecruitingJZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid TumorsThis Phase 1 first-in-human study will investigate the safety, tolerability, pharmacokinetics (PK), immunogenicity, and preliminary antitumor activity of JZP898 monotherapy as…NCT06108050·Encinitas, California and 9 others

PreviousPage 45 of 545Next

Diabetes

in Nashville

Heart Diseasein Nashville